In Switzerland, more than 1,100 patients die every year from leukaemia and so-called lymphomas, malignant lymphocytes in the lymph nodes or bone marrow. Despite the wide range of treatment options, there is a great need to optimise the choice of therapy for blood cancer patients who are affected by a relapse. This is exactly what we aim to do with our research project “INTeRCePT”. We present our study with patients treated at the Children’s Hospital Zurich and the University Hospital.

INTeRCePT is a project of the translational research center The LOOP Zurich